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Cancer primary prevention clinical trials are different from disease—
specific treatment trials. Prevention trials t\ picallv I include
participants who are othersk Re healthy, devoid of symptoms and
thus require that to\icities or ‘ide ci eels trom an inters eritmon be
minimal, , require large numbers of subjects to detect a difference
between the intervention and control groups. and 3) require long
study and lbllos—up periods to detect differences in outcomes
related to all-cause survival. cancer-specit mc stirs i sal and qualit\ ot
life. SELECT. the Selenium and Vitamin E Cancer Prevention Trial
presented here, otters the opportunity to men in Hawaii to part mci—
pate in a clinical trial and contribute to our scientific understanding
and control of prostate cancer.
Carcinoma of the prostate is the most comnnion tumor in the Luited
States with I 593)0(1 ness cases and 30.20ff deaths expected in 2t)02.
in hawaii. estimates for prostate cancer in 2002 are 700 new eases
and 100 prostate cancer-related deaths. Histologic evidence of the
disease may occur in as litany of 34ff of men in their fifth decade.
and tip to 7( P4 of men 50 years of age and older. \\ hile i me in ti ye
L’S. men s ill he diagnosed with prostate cancer during his lifetime.
onl 3ff of men are expected to die of [he disease, The menu of
treatment options for localized prostate cancer includes radical
prostatectomy, external-beam radiation therapy. hrachvtherapv.
hormonal treatments or surveillance. Issues that contimund the
ch nec of ti’eatmcnt include side et’ffcts of treatment. the inability to
predict the natural historr of a giveti cancer, and patieiit comorhid
conditions that may ultimately affect the patient’s likelihood of
succumbing to prostate cancer morhidit\ and mortality. The ques
tion of \\ hether screening digital m-ectal examination and PSA
improve mortal mt\ and morbidit\ awaits the results ol ongoing
clinical trials such as the Prostate, lung. Colon, and Osarian
PLCO) trial sponsored by the National Cancer Institute. I-losves er,
prostate screening appears to have resulted in a substantial stage
migration in diagnosed prostate cancer’. to earlier. potentiall cur
able stages metastatic prostate cancer at initial diagnosis may
become a historical t)jotnote.
Factors that increase the risk for prostate cancer include increas
ing age. prostate cancer in first degree male relatives, the male
hormonal testosteroite nnliett. race and dictar\ tat. Sonic studies
a’.’.ocmate increased dietar intake ot Eu its and ecetab e” svi t h a
reduced risk of prostate cancer.
Although it mar he increasinglr evident that dietary choices play
a role in the development of prostate and other cancers. changing
patterns oi dietarr behas or and life—long inter\ ention niakes this
stiategy difficult in practice. Since the I )X0”.. ehemopres ention.
the use nt natural or ‘.vnthetic substances to reduce the risk of
des eloping cancer, has become an important locus 01 National
Cancer institute—sponsored clinical trials. Since the development of
prostate cancer appears to he age—dependent. any intervention that
reduces the incidence of clinicallr significant disease by five, 1(1 or
I 5 rears ss ould significantly reduce prostate cancer morbidity and
mortal itr . For the chemopreveni ion of pms wtate eancem’. a number
options has e been cons idered: retirtoids. DFMO. inhibitors of elm
lesterol hiosnthesis, alpha—tocopherol. anti—androgens and 5—alpha
reduetase iuhihitors. Recognition of the importance of the audio-
genie milieu on the prostate in the deselopinent of prostate cancer
resulted in the Prostate Cancer Prevention Trial PCPTi using
finasteride ( Proscar). This trial began accrual in October 1993 and
ended in May 1997 with enrollment of over I 5.00k participants
nationwide. The study tests the ahihtv of finasteride. a 5—alpha
i’cductasc mu ihitor. on red uci ne pu tstaie gland di hr drotestostert inc
amid, hence. a possible reduction ni the incidence of prostate cancer.
Euial analr sis is expected in 2004.
Primary prevention of prostate cancer through dietary supple—
nientation now appears to he a promising strategy to ‘educe the
morbidity and mortality ot thm disease. Secondarr analyses of data
from two prospective. randomited cancer pi’es ention tm’mals ss Ui
selenium arid s itammn F suggested these two agents tor a second
large—scale clinical trial. In a clinical trial conducted by Clark et al..
prostate cancer incidence svas reduced by two-thirds among men
recemviimg dadr selenium supplementati in. In the Alpha—Toco—
pheri;ml. Beta—Carotene i A’I’BC i Cancer Prevention Studr carried out
in Finland. theme was a one—third redtiction m prostate cancer
incidence and a 40ff reduction in prostate cancer mortality in men
ramidomized to receive vitamin E. A confirmatory trial ..SELECT,
the Selenium and Vitaittmn F Cancer Pm’es entiomi Trial. ss ith prostate
cancer incmdemiee as one of the primw em’idpoints will substantiate
these lindiimgs.
The primary objective of SELECT is to assess the effect of
selenium and vitamin F. either alone or in combination, on the
inc i deuce U’ prostate cancer diagnosed dim i’m ng rout m ic cliii ical p’—
[ice. Secondary objective’. mnclude assessmne the impact ot selenitimu
atmd itani m F on the m nicidemice ot lung cancem’, to Ii m cancer amid all
other caticers: on caticer—specil ic survival and oyerall survival,
Quality of lil’e. evaluation of miiolecufar and genetic markers of
camicer risk. other hiomnai’ker. amid measum’es ot nutm’ient intake will
also be assessed. An amicillarr studr cal led PREAI)VISE lam’
Pies etttion of M,lmeirner’s Disease hr \mtanmin F and Selenium
Trial, wiN recrtnt from the SELECT participant pool. screening for
changes in short-tertii memory or other forms of dementia.
Tzni’ollutcnt to SELEC1 . a National Cancer Institute-sponsored
trial. hccan in Jul 2002. More than 32.t)m)m) men at over -0)0 sites n
the United States. Puerto Rico. and Canada ss ill he i’ecruited.
Enrollment is estintated to take five years. with the entim’e duration
of the trial being 1 2 years, The University of Hasvaii Minority-
Based (‘limiical ()ncoloer Program. administemed hr the Cancer
Rc’.eac h (‘enterof Hawaii. isone of the sites selcetedttconduct tIns
Eligible males must be age 55 or older (age 50 and older for
African-American men). have had a non-suspicious i)RE and a total
PS\ less than or equal to —Ili ng!inl within 364 dar s of randomiia—
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Classified Notices
To place a classified notice:
HMA members—Please send a signed and type
written ad to the HMA office. As a benefit of member
shIp. HMA members may place a comptrnentary one
t:me classified ad in HMJ as space is available.
Nonmembers.—Please call 536-7702 for a non-
member form, Rates are $1.50 a word wiTh a minimum
o1 20 words or $30. Not commissionable. Payment
must accompany wnften order.
Locum Tenens
BOARD CERTIFIED FP—avatable for summer Locum
Tenens office coverage. HI license, ACLS. NALS.
liability insurance provIded. Please call 9131685-7494.
For Sale
LLuHer R,HL ,ii Ii (cnn,’ II, ‘(if/Ic. oJiiiiIifrI /10//i 7). I6
tn/n. Additional eligmhilit criteria may he ohtained h contacting the study site.>
Participants will i’cceive either 2(1(1 meg of seleniunn 4(X) mc of x itanmin F. both, or placehos
for up to 12 scars. Blood samples and toenail elippines xxiii he requested from all
participants. Participants xx ill also he asked to take part in the PREADV 1SF. However,
declining to provide samples or to take pa-i in the PREAI)VISE will not affect their
parttcipatiotm in SELECT.
For more intormatton in Hawaii. contact the Clinical Trials Unit, (8O8)5862979. For
information on study sites outside of Hawaii, call the Cancer Information Service of Hawaii
at I —SUO4—CA\CER. In Canada, call the Canadian Cancer Society’s Cancer Information
Serx ice Hit l-SXX-93-3333.
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FOR SALE— Medical office epuipfmenf including. EKG
machine Burdick E3501 i: Weich-Allyn wall mount
ofoscope ophfhalmoscopei blood pressure cuff: hear
ing boofh Industrial Acoustics) and audiometer lWelch
Allym. Pulmonaryfuncfion machine. Lighfly used. 808-
877-5811.
Physician Wanted
KAUAI, HAWAII— Seeking a BC/BE Primary Care
internist. Interests in rheumatology, infectious diseases
and geriatrics are welcome. Proficiency in treadmill
stress testing desired Kaua Medical Clinic is a 65-
physician muitispecialty medical group affiliated with
Wilcox Memorial Hospital and Hawaii Pacific Health.
This opportunity offers excellent quality of life in a safe,
spectacular y beautful. family oriented, rural commu
nity Competitive salary. benefits and relocation pack
age Send/fax CV to’ M. Keyes-Saiki. Kauai Medical
Clnic 3 3 20 Kuhio Hwy Suite B, Lihue, HI 96766-
1098 Fax 1808> 246 1625. Email: mkeyes
aikiw lcoxhealth.org
KAUAI. HAWAII— Kauai Medical Clinic a 65-pnysician
mjlfi pecinity medica group i casino a BC BE PM&R
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